Quantcast

Latest Alzheimer's Stories

2014-06-16 12:29:07

Sunrise-to-Sunset Event Raises Awareness and Funds to Fuel the Alzheimer's Association® CHICAGO, June 16, 2014 /PRNewswire-USNewswire/ -- On June 21, 2014, The Longest Day(®) participants across the globe will join with the Alzheimer's Association(®) to honor those living with Alzheimer's disease and their caregivers. The Longest Day is a sunrise-to-sunset challenge to raise awareness and funds to fuel the care, support and research programs of the Alzheimer's Association. Held on the...

2014-06-16 08:29:26

NAPLES, Fla., June 16, 2014 /PRNewswire/ -- AgingCare.com has launched FadeToBlank.org, a new interactive, educational website that for the first time tells the candid, personal stories of people living with Alzheimer's disease. FadeToBlank.org offers a unique opportunity to learn what it really feels like to live with this degenerative disease. "While the majority of industry groups are focused on research and funding, care approaches and support for family caregivers, we are...

2014-06-10 20:23:05

- Alzheimer's Association Statement - WASHINGTON, June 10, 2014 /PRNewswire-USNewswire/ -- Today, the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies allocated an additional $100 million in its fiscal year 2015 funding bill for Alzheimer's research. The Alzheimer's Association commends Chairman Tom Harkin (D-IA) and Ranking Member Jerry Moran (R-KS) for their ongoing commitment to Alzheimer's, a terminal disease with no...

2014-06-05 08:29:40

NEW YORK, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Alzheimer%s Disease Therapeutics and Diagnostics: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimer/alzheimers_disease_therapeutics_diagnostics_global_markets.html INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC's goal in conducting this study was to determine the current status of Alzheimer's disease treatments and diagnostics and assess the growth potential of this...

2014-06-04 04:21:45

VIENNA, June 4, 2014 /PRNewswire/ -- AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients. Upon treatment with AD04, effects consistent with disease modification were achieved for at least 18 months in 47% of treated patients. This beneficial effect was dose dependent and more effective in...

2014-06-02 12:29:55

Alzheimer's Association® Invites Everyone to Go Purple to Raise Awareness of Alzheimer's Disease and Brain Risk CHICAGO, June 2, 2014 /PRNewswire-USNewswire/ -- There are at least 44 million people worldwide living with Alzheimer's disease and other dementias, and those numbers are expected to grow to 76 million by 2030. During the inaugural Alzheimer's & Brain Awareness Month this June, the Alzheimer's Association(®) is asking people around the world to wear purple - the color of the...

2014-05-21 16:27:02

PITTSBURGH, May 21, 2014 /PRNewswire/ -- Cognition Therapeutics Inc. (CogRx), an innovative research and drug discovery organization focused on the development of novel disease-modifying therapeutics for neurodegenerative diseases, announced today that its small molecule soluble Abeta receptor antagonist program for the treatment of Alzheimer's disease (AD) has been selected for funding by the National Institute on Aging (NIA)/NIH Alzheimer's Disease Drug Development Program (U01)....

2014-05-05 12:29:07

"Until there is a cure, we must care for the carer." OMAHA, Neb., May 5, 2014 /PRNewswire/ -- As the world population ages, diseases such as Alzheimer's become more prevalent. And with a surplus of people who need care, there is often a shortage of those who are able and willing to give care. Paul Hogan, chairman and co-founder of Home Instead Senior Care®, addressed ways to support caregivers at the 29(th) Alzheimer's Disease International Conference....

2014-05-02 12:27:14

Drug Could Be the First to Slow the Progression of Alzheimer's Disease NEW YORK, May 2, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it raised more than $1.1 million in support of a clinical trial to test an existing drug for the treatment of Alzheimer's disease. The $1.1 million was generated during the "Fund a Scientist" auction at its Eighth Annual Connoisseur's Dinner on May 1, 2014, and awarded to Jeffrey Cummings, MD,...

2014-05-01 16:30:38

George Vradenburg Appointed to Council WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- The World Dementia Council, meeting for the first time in London, England on Wednesday, agreed to priorities for the upcoming year and to mobilizing a worldwide effort to find a cure for Alzheimer's and dementia. Supported by the UK Government, and an outgrowth of the 2013 G8 Dementia Summit, the World Dementia Council was created to champion innovation in dementia across diagnosis, treatment, and care...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'